School of Medicine

Researchers at Washington University are looking to find new ways to design vaccines to protect against inflammation in the brain that causes dementia.

WashU Medicine secured $683 million in research funding from the National Institutes of Health (NIH) in 2024, placing the school at No. 2 in NIH funding nationwide for the second year in a row.

Burel R. Goodin, a professor of anesthesiology at WashU Medicine, has received more than $3 million from the National Institutes of Health (NIH) to support postdoctoral training.

A new, artificial intelligence-based method of analyzing mammograms, developed by researchers at WashU Medicine, identified individuals at high risk of developing breast cancer more accurately than the standard, questionnaire-based method did.

Results from a clinical trial conducted at WashU Medicine showed adding the investigational drug itacitinib to standard care for “half-matched” stem cell transplantation may reduce rates of graft-versus-host disease.

The Foundation for Anesthesia Education and Research has announced that Alex Evers, MD, the Henry E. Mallinckrodt Professor of Anesthesiology at Washington University School of Medicine in St. Louis, will receive the foundation’s 2024 Mentoring Excellence in Research Award. 

WashU Medicine researchers are helping transform mind-bending psychedelics into treatments for devastating mental illnesses.

WashU researcher Deanna Barch was recognized by two national organizations for her work on schizophrenia and other mental health conditions.

Siteman Cancer Center’s new building for outpatient care will be named the Gary C. Werths Building. A transformative commitment by the late Werths and his husband, Richard Frimel, will support cancer research and medical student scholarships.

The Siteman Blood Cancer Center delivers tomorrow’s treatments today.